Glucagon-like peptide-1 (GLP-1) diet pills represented by simeglutide are popular all over the world. In China, simeglutide weight loss indications have not yet been approved. The approved indications are for lowering sugar and are covered by medical insurance. Since simeglutide is covered by medical insurance, does that mean weight loss can also be reimbursed by health insurance? In response to this question, on April 16, the National Health Insurance Administration responded on its public account saying, “No matter how 'amazing' diet pills are, they cannot be covered by medical insurance.” In response, the National Health Insurance Administration explained that in order to promote the construction of a healthy China, guarantee the basic medication needs of insured personnel, and raise the level of scientific and refined management of basic medical insurance medication use, the National Health Insurance Administration issued the “Interim Measures on the Administration of Basic Medical Insurance Medication Use” in 2020, which clearly stipulate that 8 types of drugs cannot be reimbursed by medical insurance, mainly enhancing sexual function, treating hair loss, weight loss, beauty, smoking cessation, and quitting alcohol are one of these categories. Not only our country, but some other countries also have similar regulations. The reason they are doing this is to protect and make good use of everyone's “life-saving money.” Employee health insurance funds are mainly paid by employers and individual employees, and two-thirds of residents' health insurance funds come from financial subsidies. One cent is hard to come by, and must be used on the “blade” of treating diseases and saving people.